ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ADAM10 | ADAM metallopeptidase domain 10 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALCAM | Activated leukocyte cell adhesion molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Mixed |
ALK | Anaplastic lymphoma receptor tyrosine kinase | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
ART1 | ADP-ribosyltransferase 1 | CD markers Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | Blood group antigen proteins CD markers Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ATP1B3 | ATPase, Na+/K+ transporting, beta 3 polypeptide | CD markers Predicted membrane proteins Transporters
| | | | | Expressed in all |
BCAM | Basal cell adhesion molecule (Lutheran blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BMPR1A | Bone morphogenetic protein receptor, type IA | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
BMPR1B | Bone morphogenetic protein receptor, type IB | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
BSG | Basigin (Ok blood group) | Blood group antigen proteins CD markers Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BST1 | Bone marrow stromal cell antigen 1 | CD markers Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BST2 | Bone marrow stromal cell antigen 2 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
BTLA | B and T lymphocyte associated | CD markers Predicted membrane proteins
| | | | | Group enriched |
BTN3A1 | Butyrophilin, subfamily 3, member A1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C5AR1 | Complement component 5a receptor 1 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CCR2 | Chemokine (C-C motif) receptor 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR3 | Chemokine (C-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CCR4 | Chemokine (C-C motif) receptor 4 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR6 | Chemokine (C-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CCR9 | Chemokine (C-C motif) receptor 9 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CD101 | CD101 molecule | CD markers Predicted membrane proteins
| | | | | Mixed |
CD109 | CD109 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Mixed |
CD14 | CD14 molecule | Cancer-related genes CD markers Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CD151 | CD151 molecule (Raph blood group) | Blood group antigen proteins CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CD163 | CD163 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD163L1 | CD163 molecule-like 1 | CD markers Predicted membrane proteins
| | | | | Mixed |
CD164 | CD164 molecule, sialomucin | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD180 | CD180 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD19 | CD19 molecule | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CD1A | CD1a molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD1B | CD1b molecule | CD markers Predicted membrane proteins
| | | | | Mixed |
CD1D | CD1d molecule | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Mixed |
CD1E | CD1e molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD200 | CD200 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CD207 | CD207 molecule, langerin | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CD209 | CD209 molecule | CD markers Predicted membrane proteins
| | | | | Mixed |
CD22 | CD22 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD226 | CD226 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD244 | CD244 molecule, natural killer cell receptor 2B4 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD247 | CD247 molecule | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CD248 | CD248 molecule, endosialin | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |